Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL5015124 | 0.86 | — | — | |
| Oxalic Acid SCHEMBL15473640 | 0.84 | MAPT (0.31) | — | |
| SCHEMBL3067310 | 0.84 | SLC22A6 (0.43) | SLC22A6TDP1SMN1; SMN2 | |
| Oxalic Acid SCHEMBL5015112 | 0.80 | ALDH1A1 (0.30) | SLC22A6 | |
| Oxalic Acid SCHEMBL15473617 | 0.78 | CA4 (0.32) | — | |
| Oxalic Acid SCHEMBL5014694 | 0.75 | BBOX1 (0.32) | — | |
| Tetrylammonium SCHEMBL5014690 | 0.70 | — | — | |
| Oxalic Acid SCHEMBL5014695 | 0.70 | — | — | |
| Oxalic Acid SCHEMBL5017042 | 0.69 | MAPT (0.30) | — | |
| Oxalic Acid SCHEMBL2420699 | 0.68 | EGLN1 (0.37) | SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080118845-A1 | IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY | SONY CORPORATION (JP) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080118845-A1 | IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY | CA2, DUOX2, OTC | SLC22A6 367/4885TDP1 1951/4885SMN1; SMN2 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.